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. LC-UV/MS spectra for retinoid standards. LC-MS traces and absorption spectra of retinoid standards used in this study. Retention time and maximum wavelength (ʎmax) of each retinoid were determined using a gradient of 10% acetonitrile for 1.5 minutes followed by 90% acetonitrile for 7.5 minutes. METHODS AND PROTOCOLS
Docking
All calculations were performed using the Schrödinger Suite. 1 The x-ray structure of ALDH1A1 was extracted from the PDB (PDB ID: 4WP7). 2, 3 The centroid of the co-crystalized inhibitor CM026 was used to define the binding pocket coordinates. The protein was prepared for docking using the protein preparation tool: metals and ions were removed, hydrogens and missing side chains were added. Retinoic acid and LEI-945 were docked into the CM026 binding pocket of ALDH1A1. A constraint was used in docking of retinoic acid for hydrogen bond formation with either the backbone of cys303 or the side chain of asn170.
Synthesis of chemical probe and inhibitor
General remarks. All reactions were performed using oven or flame-dried glassware and dry solvents. Reagents were purchased from Sigma Aldrich, Acros, Biosolve, VWR, Fluka, Fischer Scientific and Merck and used as received unless stated otherwise. Inhibitor NCT-505 was prepared as previously described. 4 Tetrahydrofuran (THF) and N,N-dimethylformamide (DMF) were stored over molecular sieves before use. All moisture sensitive reactions were performed under a nitrogen atmosphere. TLC analysis was performed using Merck aluminum sheets (TLC silica gel 60/Kieselguhr F254. Compounds were visualized using a solution of KMnO4 (7.5 g), K2CO3 (50 g), 10% NaOH (6 mL) in H2O (1 L). Column chromatography was performed using Screening Device B.V. silica gel (particle size of 40 -63 µm, pore diameter of 60 Å) with the indicated eluents.
1 H-and 13 C-NMR spectra were recorded on Brüker AV-400 (400 MHz and 101 MHz, respectively) or Brüker AV-500 MHz (500 MHz and 150 MHz, respectively) using CDCl3 as solvent. Chemical shifts are reported in ppm (δ) relative to the residual solvent peak or tetramethylsilane. Coupling constants are given in Hz. High-resolution mass spectrometry (HRMS) analysis was performed with a LTQ Orbitrap mass spectrometer (Thermo Finnigan), equipped with an electrospray ion source in positive mode (source voltage 3.5 kV, sheath gas flow 10 mL/min, capillary temperature 250 °C) with resolution R = 60000 at m/z 400 (mass range m/z = 150 -2000) and dioctyl phthalate (m/z = 391.28428) as a "lock mass", or with a Synapt G2-Si (Waters), equipped with an electrospray ion source in positive mode (ESI-TOF), injection via NanoEquity system (Waters), with LeuEnk (m/z = 556.2771) as "lock mass". Eluents used: MeCN:H2O (1:1 v/v) supplemented with 0.1% formic acid. The high-resolution mass spectrometers were calibrated prior to measurements with a calibration mixture (Thermo Finnigan). The retinoids were handled under dark conditions using amber colored flasks or aluminum foil when containing more than 3 conjugated double bonds. Retinoid intermediates were stored in the dark under nitrogen at -30 °C and final compounds as powder or as DMSO stock at -80 °C under nitrogen atmosphere. For further information on retinoid handling and storage we refer to the review from Barua and Furr. 5 No unexpected or unusually high safety hazards were encountered. (E)-4-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)but-3-en-2-one (2): A solution of purified β-Ionone (1.0 g, 5.2 mmol), recrystallized NBS (1.2 g, 6.8 mmol) and AIBN (43 mg, 0.26 mmol) in tetrachloromethane (50 mL) was refluxed at 80 °C for 2 hours and was then allowed to cool down. 6 The solution was filtered and then DMF (12.5 mL) and Na2CO3 (1.3 g) were added. The tetrachloromethane was distilled off and the mixture cooled to room temperature. Et2O (100 mL) was added and the solution was filtered. Then concentrated sulfuric acid (2.0 mL, 38 mmol) was added and the reaction was stirred overnight at 4 °C. The reaction mixture was then poured onto ice water and then 50% NaOH aq. was added. After stirring for several minutes the mixture was extracted with Et2O and the organic layer washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure. Purification of the residue by column chromatography (EtOAc/Pent) afforded the title compound 3 (3.5 g, 14 mmol, 23%; 32% based on 71% conversion) as an orange oil and recovered compound 2 (3. 
SYNTHESIS OF RETINAL SCAFFOLD BASED ACTIVITY BASED PROBE LEI-945

Bromo((2E,4E)-3-methyl-5-(2,6,6-trimethyl-4-(prop-2-yn-1-yloxy)cyclohex-1-en-1-yl)penta-2,4-dien-1-yl)triphenyl-ʎ 5 -phosphane (5):
To a stirred mixture of 4 (3.0 g, 11 mmol) in MeOH (60 mL) was added triphenylphosphine hydrobromide (4.1 g, 12 mmol). 8 The reaction mixture was stirred overnight at room temperature and then concentrated under reduced pressure. H2O was added and the product extracted with DCM. The organic layer was washed with brine, dried over Na2SO4, filtered, concentrated and purified by column chromatography (EtOAc followed by MeOH) affording title compound 5 (5. 
Ethyl (E)-4,4-dimethoxy-3-methylbut-2-enoate (7):
To a stirred solution of trimethyl orthoformate (8.6 mL, 77 mmol) and ethyl 3-methyl-4-oxocrotonate 6 (10 g, 70 mmol) in MeOH (40 mL) was added pTsOH (268 mg, 1.4 mmol). The mixture was stirred for 2 hours and then H2O (100 mL) was added. The product was extracted with Et2O (3 x 200 mL). The combined organic layers were washed with NaHCO3 aq., brine and dried over Na2SO4, filtered and carefully concentrated affording title compound 7 (13.1 g, 69 mmol, quant.) as a colorless oil. Rf (10% Et2O in Pent) = 0. 
(E)-N,4,4-Trimethoxy-N,3-dimethylbut-2-enamide (8):
To a stirred solution of 7 (2.0 g, 11 mmol) in dry THF (30 mL) under N2 at 0 °C was added N,O-dimethylhydroxylamine hydrochloride (1.6 g, 16 mmol) followed by iPrMgCl (16 mL, 32 mmol, 2M in THF). The reaction was stirred for 3 hours at room temperature and was then quenched with sat. NH4Cl aq. The mixture was extracted with Et2O and the organic layer washed with brine, dried over Na2SO4, filtered and concentrated affording title compound 8 ( 
(E)-N-methoxy-N,3-dimethyl-4-oxobut-2-enamide (9):
To a stirred solution of 8 (0.50 g, 2.5 mmol) in DCM (20 mL) at room temperature was added a solution of TFA (2.5 mL) in H2O (2.5 mL). The reaction mixture was stirred for 2 hours and then K2CO3 was added until the pH was 8. The water layer was then extracted with DCM. The combined organic layers washed with brine, dried over MgSO4, filtered and concentrated affording title compound 9 (378 mg, 2.5 mmol, quant.) as a yellow oil. Rf (50% EtOAc in Pent) = 0. 83 mmol) in dry THF (4 mL) at -78 °C under N2 was added n-BuLi (0.5 mL, 1.6M in hexane, 0.8 mmol). The mixture was stirred for 30 minutes at -78 °C and then 9 (0.12 g, 0.76 mmol) dissolved in dry THF (1 mL) was added. The reaction was stirred for 1 hour at -78 °C and was then allowed to reach room temperature in 2 hours. Then the reaction was quenched with sat. NH4Cl aq. and extracted with Et2O. The combined organic layers were washed with H2O and brine, dried over MgSO4, filtered and concentrated. Purification of the residue by column chromatography (EtOAc/Pent) afforded title compound 10 (139 mg, 0.35 mmol, 46%; 1:1 4E/Z) as a yellow oil. Rf (50% Et2O in Pent) = 0.8. NMR spectra are obtained from the mixture of stereoisomers. 1 (4E,6E/Z,8E,10E)-5,9-Dimethyl-11-(2,6,6-trimethyl-4-(prop-2-yn-1-yloxy)cyclohex-1-en-1-yl)undeca-1,4,6,8,10-pentaen-3-one (LEI-945): To a solution of 10 (0.10 g, 0.25 mmol) in THF (1 mL) at 0 °C under N2 was added vinyl magnesium bromide (0.27 mmol, 0.30 mL) dropwise. The solution was then stirred for 2 hours at room temperature and then quenched with sat. NH4Cl aq. The mixture was then extracted with Et2O and the organic layer washed with brine, dried over Na2SO4, filtered and concentrated. Purification of the residue by column chromatography (EtOAc/Pent) afforded title compound LEI-945 (39 mg, 0.11 mmol, 43%; 7:3 6E/Z) as a yellow oil. The E/Z mixture was inseparable and prone to further isomerization under the influence of light. As retinoids are rapidly converted in vivo into their biological equilibrium of stereoisomers, LEI-945 was used as the reported E/Z mixture. 9, 10 Rf (10% EtOAc in Pent) = 0.9. NMR spectra are obtained from the mixture of stereoisomers. 1 
SYNTHESIS OF RETINAL SCAFFOLD BASED INHIBITOR STA-186
Reagents and conditions: a) vinylmagnesium bromide, THF, 18 h, 95%; b) PPh3HBr, 18 h, 90%; c) n-BuLi, 9, THF, -78 °C to rt, 2 h, 43%; d) vinyl magnesium bromide, THF, 2 h, 29%. (2E,4E/Z,6E,8E)-N-Methoxy-N,3,7-trimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8 tetraenamide (13): The title compound 13 was synthesized from 9 (0.13 g, 0.83 mmol) and 12 (0.50 g, 0.92 mmol) as described for compound 10. This yielded 13 (0.12 g, 0.36 mmol, 43%; 1:1 4E/Z mixture) as a yellow oil. Rf (50% EtOAc in Pent) = 0.8. NMR spectra are obtained from the mixture of stereoisomers. 1 
Biological methods
ALDH plasmids. For the preparation of the different constructs, full length human cDNA was purchased from Source Bioscience and cloned into mammalian expression vector pcDNA3.1, containing genes for ampicillin and neomycin resistance. hALDH1A1, hALDH1A2, hALDH1A3 and hALDH3A2 were cloned into pcDNA3.1. A FLAGlinker was cloned into the vector at the C-terminus of hALDH1A1, hALDH1A2 or hALDH1A3. EPHX1 (OHu14852D) was purchased directly from GenScript. Two step PCR mutagenesis was performed to substitute the active site cysteine for an alanine in the hALDH1A3-FLAG to obtain hALDH1A3-C314A-FLAG. All plasmids were grown in XL-10 Z-competent cells and prepped (Maxi Prep, Qiagen). The sequences were confirmed by sequence analysis at the Leiden Genome Technology Centre.
Cell culture. U2OS cells were grown in DMEM with stable glutamine and phenol red with 10% New Born Calf serum, penicillin and streptomycin at 37 °C and 7% CO2. A549 cells were grown in DMEM with stable glutamine and phenol red with 10% New Born Calf serum, penicillin and streptomycin at 37 °C and 5% CO2. The breast cancer cell lines BT-20, HCC38, MCF7, MDA-MB-231, MDA-MB-468, SK-BR-3 and SK-BR-7 were grown in RPMI-1640 with stable glutamine and phenol red with 10% Fetal Calf serum, penicillin and streptomycin at 37 °C and 5% CO2. Medium was refreshed every 2-3 days and cells were passaged twice a week. Cell lines were purchased from ATCC and were regularly tested for mycoplasma contamination. Cultures were discarded after 2-3 months of use.
Transient transfection of U2OS cells. One day prior to transfection 4*10
5 U2OS cells were seeded in a 6-wells plate. Cells were transfected by addition of a 3:1 mixture of polyethyleneimine (6 µg) and plasmid DNA (2 µg) in 200 µL serum free medium per well. The medium was refreshed after 24 hours and after 48 hours, the cells were used for subsequent assays.
In-situ activity-based protein profiling. Growth medium from cells grown in 6-wells plate was removed and 1 mL serum free medium containing probe LEI-945 (1 µM, 0.1% DMSO) was added. The cells were then incubated for 1 hour. The medium was then removed, the cells were washed with 2 mL PBS and then harvested in 1 mL PBS using a cell scraper. The cells were moved to an Eppendorf tube and the suspension was centrifuged for 5 minutes at 1200 rpm. The PBS was removed and the samples were snap frozen and stored at -80 °C until use.
In-situ competitive activity-based protein profiling. Growth medium from cells grown in 6-wells plate was removed and 1 mL serum free medium containing inhibitor or DMSO as vehicle was added (0.1% DMSO). After 1 hour of incubation 1 mL of serum free medium containing probe LEI-945 (2 µM, 0.1% DMSO) was added. The cells were then incubated for another hour. The medium was then removed, the cells were washed with 2 mL PBS and then harvested in 1 mL PBS using a cell scraper. The cells were moved to an Eppendorf tube and the suspension was centrifuged for 5 minutes at 1200 rpm. The PBS was removed and the samples snap frozen and stored at -80 °C until use.
CuAAC reaction and in-gel fluorescence analysis. Cell pellets were thawed on ice, lysed by addition of icecold lysis buffer (MilliQ, 1x protease inhibitor cocktail (Roche cOmplete EDTA free)) and incubated on ice (15-30 min). The protein concentration was determined by a Quick Start TM Bradford Protein assay (Bio-Rad). The protein fractions were diluted to a total protein concentration of 1 mg/mL. From each sample 40 µL was taken and treated with 5 µL from a freshly prepared "click" mixture containing 9 mM CuSO4 (2.5 µL/sample, 18 mM in H2O), 45 mM NaAsc (1.5 µL/sample, 150 mM in H2O), 1.8 mM THPTA (0.5 µL/sample, 18 mM in DMSO) and 9 µM Alexa Fluor 647 azide (0.5 µL/sample, 90 µM in DMSO from Thermo Fischer Scientific). The samples were incubated for 1 hour at 37°C and then 15 µL 4x SDS page sample buffer was added. The samples were denatured at 100°C for 5 minutes. 8 µg per sample was resolved on a SDS-PAGE gel (10% acrylamide, 180V, 75 min). Gels were visualized with a ChemiDoc XRS (Bio-Rad) using Cy3 and Cy5 multichannel settings (605/50 and 695/55, filters respectively) and stained with Coomassie or transferred to a 0.2 µm polyvinylidene difluoride membranes by Trans-Blot Turbo TM Transfer system (Bio-Rad) after scanning. Fluorescence was normalized to Coomassie staining or to FLAG-tag signal and quantified with Image Lab (Bio-Rad). IC50 curves were fitted with Graphpad Prism ® 7 (Graphpad Software Inc.).
Western Blot.
Proteins were transferred to a 0.2 µm polyvinylidene difluoride membranes by Trans-Blot Turbo TM Transfer system (Bio-Rad). Membranes were washed with TBS (50 mM Tris, 150 mM NaCl), washed with TBS-T (50 mM Tris, 150 mM NaCl, 0.05% Tween 20) and then blocked with 5% milk in TBS-T for 1 hour at room temperature. Membranes were then incubated with primary antibody in 5% milk TBS-T (FLAG, 4-HNE: 1 h, RT), washed three times with TBS-T, incubated with matching secondary antibody in 5% milk TBS-T (1 h, RT) and washed with TBS-T and TBS. The blot was developed in the dark using an imaging solution (10 mL Luminol, 100 µL ECL enhancer and 3 µL H2O2) and chemiluminescence was visualized using a ChemiDoc XRS (Bio-Rad). The signal was normalized to Coomassie staining and quantified with Image Lab (Bio-Rad). Primary antibodies: monoclonal mouse anti-FLAG (1:5000, Sigma-Aldrich, F3165). Secondary antibodies: HRP-coupled goat-antimouse (1:5000, Santa Cruz, sc2005).
Flow cytometry.
Cells from the different cell lines were used in the logarithmic growth phase for analysis with flow cytometry. Aldefluor assay (Stemcell, Cologne, Germany) was performed according to manufacturer's protocol. Subsequently, cells were stained with CD24 APC (Clone ML5, 1:100), CD44 PE Cy7 (Clone BJ18, 1:800), CD133 PE/Dazzle 594 (Clone 7, 1:100, all Biolegend, London, United Kingdom). Just before acquiring, DAPI (Invitrogen, Bleiswijk, the Netherlands) was added as a live death stain (1:40 000). Samples were acquired on LSRFortessa X20 (BD Bioscience, Mountain View, CA, USA) and data was analyzed with Flowjo software (Tree Star, San Carlos, CA, USA).
Cell viability and proliferation. Breast cancer cells were grown to 80% confluency in 10 cm plates. Cells were then seeded in a 96-wells plate depending on their rate of growth (BT-20: 12 k/well; MDA-MB-468 & SK-BR-3: 10 k/well; SK-BR-7 & HCC38: 8 k/well; MDA-MB-231: 4 k/well). For the SRB proliferation assay cells were also seeded on an extra plate to be able to determine the starting point protein content. Cells were allowed to adhere overnight and were then treated with vehicle (0.1% DMSO) or inhibitor NCT-505 (30 µM, 0.1% DMSO) in 100 µL RPMI medium. Cells were then incubated for 72 hours. For the MTT viability assay another 100 µL of medium containing MTT (1 mg/mL) was added and the cells were incubated for another 4 hours. The medium was then removed and the formazan crystals were dissolved in 100 µL DMSO during 1 hour in the stove. The absorbance was then measured in a CLARIOstar Plus plate reader at 570 nm. For the SRB assay cells were fixated by incubation with 30 µL 50% TCA for 1 hour at 4 °C. The plates were washed 5 times with water and dried. 60 µL 0.4% SRB was added and incubated for 30 minutes at room temperature. The plates were then washed another four times with acetic acid (0.1%) and dried. The SRB was dissolved by adding 150 µL Tris (10 mM) and incubating for 30 minutes at room temperature. Absorbance was then measured at 540 nm on a CLARIOstar Plus plate reader. Graphpad Prism ® 7 (Graphpad Software Inc.) was used to plot data and calculation of mean values and standard deviation.
Determination of ATP levels. MDA-MB-468 cells were seeded in 96-wells plates at 10 k/well. Cells were allowed to adhere overnight and were then treated with vehicle (0.1% DMSO) or inhibitor NCT-505 (30 µM, 0.1% DMSO) for 4 hour. The plate was then allowed to equilibrate for 30 minutes at room temperature. CellTiter-Glo assay (Promega) was then performed according to manufacturer's protocol. Measured on a CLARIOstar Plus plate reader and Graphpad Prism ® 7 (Graphpad Software Inc.) was used to plot data and calculation of mean values and standard deviation.
Synergy of NCT-505 and RSL3. MDA-MB-468 cells were seeded in 96-wells plates at 10 k/well. Cells were allowed to adhere overnight and were then treated with varying concentrations of NCT-505 or RSL3. Cells were then incubated for 72 hours and a MTT assay was performed as described above. Graphpad Prism ® 7 (Graphpad Software Inc.) was used to plot data and calculate IC50 values. Cells were then treated with vehicle (0.1% DMSO), NCT-505 (3 µM, 0.1% DMSO), RSL3 (30 nM, 0.1% DMSO, Selleck Chemicals) or a combination of NCT-505 (3 µM) and RSL3 (30 nM). Cells were then incubated for 72 hours and a MTT assay was performed as described above. Graphpad Prism ® 7 (Graphpad Software Inc.) was used to plot data and calculation of mean values and standard deviation. The IC28 values for both NCT-505 and RSL3 were calculated and used to determine the combination index value.
In situ activity-based proteomics
Sample preparation. Protocol adapted from previously described procedure.
11 Cells were treated in-situ, harvested, lysed and adjusted to 1 mg/mL protein concentration as described above. 250 µL was taken from each sample and to this 25 µL freshly prepared "click" mixture containing 1 mM CuSO4 (2.5 µL/sample, 100 mM in H2O), 5 mM NaAsc (1.25 µL/sample, 1 M in H2O), 0.4 mM THPTA (1 µL/sample, 100 mM in DMSO), 40 µM biotin-N3 (2.5 µL/sample, 4 mM in DMSO) and MilliQ (17.75 µL/sample) was added. Samples were incubated for 1 hour at 37 °C while shaking (300 rpm). Excess click reagents were then removed by chloroform/methanol precipitation followed by another wash with methanol. Precipitated proteomes were then suspended in urea buffer (250 µL, 6 M urea and 25 mM ammonium bicarbonate), DTT (2.5 µL, 1 M) was added and the mixture was then incubated for 15 min at 65 °C while shaking (600 rpm). The samples were then allowed to cool down to RT and then alkylated by addition of iodoacetamide (20 µL, 0.5 M) for 30 minutes at RT in the dark. Addition of SDS (70 µL, 10% (v/v)) was followed by heating at 65 °C for 5 minutes. For each sample 50 µL 50% slurry of Avidin-Agarose from egg white (Sigma-Aldrich) was washed three times with PBS and transferred in PBS (1 mL) to a 15 mL tube. To this another 2 mL of PBS was added followed by the corresponding proteome sample. The beads were incubated with the proteome for 2 hours at room temperature using an overhead shaker. The beads were then isolated by centrifugation (2 min, 2500g), washed with SDS in PBS (0.5% (w/v)) and washed three times with PBS. The beads were then transferred to low-binding Eppendorf tubes and proteins were digested overnight at 37 °C and 950 rpm in 250 µL digestion buffer (100 mM Tris, 100 mM NaCl, 1 mM CaCl2, 2% acetonitrile and 0.5 µg sequencing grade trypsin (Promega)). Digestion was stopped by addition of formic acid (12.5 µL) and the beads filtered off by centrifugation (2 min, 600g) using a Bio-Spin column (Bio-Rad). Samples were then desalted using stage tips, collected in low-binding Eppendorf tubes, concentrated using a SpeedVac (Eppendorf) and stored at -20 °C until reconstitution before measurement 12 . All samples were prepared in at least three biological replicates.
LC-MS/MS measurement and analysis.
Samples were reconstituted in LC-MS sample solution (50 µL, 3% acetonitrile/0.1% formic acid/20 fmol/µL enolase). Samples were then analyzed using a NanoACQUITY UPLC System (Waters) coupled to a SYNAPT G2-Si high-definition mass spectrometer (Waters) as previously described. 11, 13 Of each sample 5 µL was loaded on a nanoEASE TM M/Z Symmetry C18 trap column (particles 5 µm, 100 Å , 180 µm x 20 mm, Waters) with 0.1% formic acid and separated on an nanoEASE TM M/Z HSS C18 T3 analytical column (particles 1.8 µm, 75 µm x 250 mm, Waters) heated at 80 °C. A multistep gradient running from 5-40% acetonitrile containing 0.1% formic acid during a 70 minute method at 300 nL/min was used to achieve peptide separation. Survey scans (m/z 50-2000 Da) were acquired in the Synapt with a scan time of 0.6 seconds in positive, resolution mode. The collision energy is set to 4 V in the trap cell for low-energy MS mode. For the elevated energy scan, the transfer cell collision energy is ramped using drift-time specific collision energies. The lock mass is sampled every 30 seconds. MS raw files were analyzed with ProteinLynx Global SERVER (PLGS, v3.0.3, Waters). The MS E identification was also performed with PLGS using the human proteome from Uniprot (uniprot-homo-sapiens-trypsin-reviewed-2016-08-29.fasta). The following parameter settings were used: low energy threshold 150 counts, elevated energy threshold 30, peptide and protein FDR 1%, enzyme specificity trypsin, max missed cleavages max 2, variable modification methionine oxidation, fixed modification carbamidomethylation cysteine, fragments/peptide 2, fragments/protein 5, peptides/protein 1 and number of peptides to measure per protein 3. For label-free quantification ISOQuant (v1.5) was used. 14, 15 Data were filtered to retain only proteins with two or more reported peptides and quantified in at least 3 replicates of the positive control (probe treated). Proteins were designated as significantly enriched by the probe when they showed 2-fold enrichment in quantification value when comparing negative control (vehicle treated) with positive control (probe treated) samples, probability as determined by a Student's t-test (p < 0.05) and Benjamini-Hochberg correction with an FDR of 10%. The processed tables have been uploaded to the supplementary information as an Excel file.
Heatmap Competitive ABPP analysis. Only proteins significantly enriched (34 proteins, volcano plot Fig. 3b) were selected for analysis. Proteins were sorted on their maximal abundance. The mean raw LFQ intensities from quadruplicate measurements were normalized to DMSO (= 0) and maximal LFQ LEI-945 (= 1) for each protein individually. The heatmap was prepared using Graphpad Prism ® 7 (Graphpad Software Inc.).
Heatmap ALDH profiles breastcancer analysis and correlation with transcriptomics and proteomics. Only ALDH enzymes significantly enriched in at least one breastcancer cell line (ALDH1A1, ALDH1A3, ALDH2, ALDH3A2, volcano plots Supplementary Fig. 14) were selected for analysis. The mean raw LFQ intensities of triplicate measurements from two independent experiments were normalized using the LFQ mean raw LFQ intensity of the enolase internal standard and averaged. Average LFQ values for each ALDH enzymes were then calculated and used to determine the fold-change log2. The heatmap was prepared using Graphpad Prism ® 7 (Graphpad Software Inc.). The log2 FC was plotted against transcriptomics and proteomics log2 FC data. Breast cancer cell line mRNA microarray data used were previously established and are available in the Gene Expression Omnibus data repository (GEO) (accession number: GSE41313). 16 Protein abundance in the breast cancer cell lines was previously analyzed using proteomics (manuscript in preparation, data available upon request).Transcriptomics data did not include the SK-BR-7 cell line. Linear regression and Pearson's correlation were calculated and plotted using Graphpad Prism ® 7 (Graphpad Software Inc.).
In situ LC-UV/MS retinal conversion assay
Sample preparation. U2OS cells were grown in 6-wells plates and transiently transfected (N = 3). After 48 hours growth medium was replaces with medium containing retinal (30 µM) with serum. Cells were incubated for 4 hours, then washed with PBS and then PBS (1250 µL) was added. Breast cancer cell lines were incubated with retinal (10 µM) for 1 hour as they were more sensitive towards prolonged exposure to retinal. Cells were harvested using a cell scraper and then suspended in PBS. 1 mL of the suspension was moved to low-binding Eppendorf tube and 250 µL to a separate Eppendorf tube used to check for successful overexpression. The low-binding Eppendorf tube was spun down at 1000 g for 5 min and then PBS was removed. Samples were snap frozen and stored at -80 °C until needed. A live/dead count was performed on the cells in the remaining Eppendorf tube after which cells were lysed using a probe sonicator (5 sec, 30% amplitude). Samples were then denatured and loaded on gel, transferred to a membrane and the overexpression visualized using anti-FLAG antibody. When required lowbinding Eppendorf tubes were thawed on ice after which acetonitrile (600 µL, LC-MS grade) was added. The cells were lysed using a probe sonicator (5 sec, 30% amplitude) and spun down (14000g, 5 min). The lysate was transferred to a new low-binding Eppendorf tube. Lysates were collected in low-binding Eppendorf tubes, concentrated using a SpeedVac (Eppendorf) and reconstituted in LC-MS sample solution (110 µL, 90% acetonitrile). Samples were vortexed, spun down (14000g, 5 min) and transferred (100 µL) to a LC-MS vial after which they were measured.
LC-UV/MS measurement and analysis.
Samples were injected onto a C18 column (50 x 4.6 mm, 3 µm; Nucleodur Gravity, Macherey-Nagel) connected to a Vanquish UHPLC system (Thermo Scientific) with a Vanquish Diode Array detector (Thermo Scientific) coupled to a LCQ TM Fleet (Thermo Scientific) via electrospray ionization (ESI). Acetonitrile and water containing TFA (0.1%) were used for chromatographic separation of the retinoids. The solvent gradient was run from 10% acetonitrile for 1.5 min and then increased to 90% for 7.5 min. UV spectra were recorded between 200 and 600 nm. A calibration curve was made from a mix of retinoid standards (retinol, retinal, all-trans retinoic acid, 9-cis retinoic acid and 13-cis retinoic acid) measured at increasing concentrations (10 nM, 25 nM, 50 nM, 100 nM, 250 nM, 500 nM, 1 µM and 2 µM; N = 2, n = 4). Samples were then measured in duplo with a washing step after each sample. Quantification was performed using Xcalibur TM software (Thermo Scientific) after which the ratio between the UV spectra selected at 324, 356 and 380 nm were calculated for each peak to determine their purity. Concentrations were calculated using the calibration curve and averaged over the two measurements. The percentages of each retinoid as part of the total amount of retinoids detected in the samples were calculated.
Live cell imaging
Cell culture and lentivirus production. HEK293T cells were maintained in high-glucose Dulbecco's Modified Eagle Medium (DMEM, HyClone) with 5% fetal bovine serum (FBS, Gemini Bio) and 2 mM glutamine (Life Technologies) at 37 °C with 5% CO2. To package lentivirus, HEK293T cells at ~70% confluency were transfected with pMDLg-RRE (gag/pol), pCMV-VSVG, pRSV-REV, and FUCCI plasmids (addgene#83841) using polyethyleneimine (PEI). Two days post-transfection, viral supernatant was filtered with a 0.45 μm polyethersulfone filter before using to infect the MDA-MB-468 cells.
Exposure and live cell imaging. Cells were seeded in Greiner black µ-CLEAR 96 well plates at 10 k/well. Prior to the NCT-505 exposure, the cells were incubated with 100 ng/ml live Hoechst 33342 in complete RPMI for 2 hours. Thereafter, the medium was refreshed with complete medium. For cell death experiment, 0.2 µM propidium iodide (PI) and Annexin-V-Alexa633 (AnV) were added to the complete medium. For the live mitochondrial membrane potential imaging, the cells were incubated with rhodamine123 dye (0.5 µM; Sigma Aldrich) in combination with live Hoechst 33342 for 2 hours, thereafter we refreshed with complete medium containing rhodamine123 only (0.075 µM) for time-lapse imaging. Then complete medium containing vehicle or NCT-505 (30 µM final concentration) was added and the plates were directly imaged onto the microscope stage for live cell imaging.
For the cell death experiment and mitochondrial membrane potential imaging, the plates were imaged at 0, 14, 24, 40, and 72 hours after the compound exposure. The cell cycle was imaged every hour after the exposure. The imaging was performed using a Nikon TiE2000 confocal laser microscope (lasers : 647 nm, 540 nm, 488 nm, and 408 nm), equipped with automated stage and perfect focus system. During the imaging, the plates were maintained in humidified atmosphere at 37 °C and 5% CO2. The experiment was conducted with 3 biological replicates with 4-5 technical replicates.
Image analysis. The quantitative image analysis was performed with ImageJ version 1.52p, CellProfiler version 2.2.0 and Ilastik 1.3.2. Firstly, the nuclei per image were segmented using the watershed masked algorithm on ImageJ. For images obtained from the cell death and mitochondrial membrane potential experiment, the nuclear segmentation was performed with Ilastik 1.3.2. The images were processed with an in house developed CellProfiler module. 17, 18 The images from the FUCCI cell line were analyzed and identified the object nuclei, geminin, and cdt with the IdentifyPrimaryObject module. The object geminin and cdt were masked with the segmented nuclei with the MaskImage module to eliminate the background. The cells expressing both proteins were identified as the yellow object by masking the images from the red channel with the geminin objects. The number of the nuclear object, geminin object, cdt object, and yellow object were counted as the outcome. For the cell death and mitochondrial membrane potential experiment , the nuclear Hoechst 33342 intensity levels, rhodamine123 integrated intensity, PI area, and Annexin V area were measured at the single cell level. The results were stored as HDF5 files. Data analysis, quality control, and graphics were performed using the in house developed R package h5CellProfiler (manuscript in preparation). 
APPENDIX
